Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
Small DM, Brown RR, Doherty DF, Abladey A, Zhou-Suckow Z, Delaney RJ, Kerrigan L, Dougan CM, Borensztajn KS, Holsinger L, Booth R, Scott CJ, López-Campos G, Elborn JS, Mall MA, Weldon S, Taggart CC.
Small DM, et al. Among authors: booth r.
Eur Respir J. 2019 Mar 28;53(3):1801523. doi: 10.1183/13993003.01523-2018. Print 2019 Mar.
Eur Respir J. 2019.
PMID: 30655278
Free article.